Latest Breaking News On - Guggenheim genomic medicines - Page 1 : comparemela.com

Calliditas to participate in upcoming investor conferences

/PRNewswire/ Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") today announced its management s participation in the.

United statesMarie galayRenee aguiar lucanderKempen life sciences conferenceEuropean union member statesEuropean commissionConferences press release engCalliditas therapeuticsNasdaq stockholmGuggenheim genomic medicinesRare disease days conferenceLotte new yorkIga nephropathyIga nephropathy treatmentEmbracing changeBetter patient

Calliditas Therapeutics: Calliditas to participate in upcoming investor conferences

STOCKHOLM, March 31, 2023 /PRNewswire/ Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") today announced its management's participation in the following investor

United statesStefan klotterRenee aguiar lucanderMarie galayConferences press release engEuropean commissionKempen life sciences conferenceEuropean union member statesNasdaq stockholmGuggenheim genomic medicinesRare disease days conferenceLotte new yorkIga nephropathyIga nephropathy treatmentEmbracing changeBetter patient

Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days

CAMBRIDGE, Mass., March 29, 2023 Wave Life Sciences Ltd. , a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases,. | March 29, 2023

United kingdomKate rauschPaul bolnoWave life sciencesWave life sciences ltdLife sciencesChief executive officerGuggenheim genomic medicinesRare disease daysNew york cityInvestor relationsWave life sciences ltd stock exchangePress releaseEvastating wve sg9999014716

Larimar Therapeutics to Participate in the Guggenheim Genomic Medicines and Rare Disease Days

Larimar Therapeutics to Participate in the Guggenheim Genomic Medicines and Rare Disease Days
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Michael celanoJoyce allaireLarimar therapeutics incLarimar therapeuticslarimar therapeutics incCompany contactWall streetGuggenheim genomic medicinesRare disease daysLarimar therapeuticslarimar therapeuticsLifesci advisorsChief financial officer

Investegate |Centessa Pharmaceuticals plc Announcements | Centessa Pharmaceuticals plc: Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Investegate announcements from Centessa Pharmaceuticals plc, Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

United statesCity ofUnited kingdomNew yorkKristenk sheppardCentessa pharmaceuticalsUpcoming investorGuggenheim genomic medicinesRare diseaseVenrock boston biotechInvestegate announcementsInvestegate company announcementsCentessa pharmaceuticals plcLobenewswire and globenewswire